Cas:77532-79-7 5-Fluoro-2-methylbenzonitrile manufacturer & supplier

We serve Chemical Name:5-Fluoro-2-methylbenzonitrile CAS:77532-79-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

5-Fluoro-2-methylbenzonitrile

Chemical Name:5-Fluoro-2-methylbenzonitrile
CAS.NO:77532-79-7
Synonyms:5-Fluoro-2-methylbenzonitrile;5-fluoro-2-methylbenzenecarbonitrile;3-FLUORO-6-METHYLBENZONITRILE;MFCD00042295;5-Fluoro-o-tolunitrile;2-cyano-4-fluorotoluene;NCR CF F1;Benzonitrile,5-fluoro-2-methyl;7700578;2-methyl-5-fluorobenzonitrile;Benzonitrile, 5-fluoro-2-methyl-
Molecular Formula:C8H6FN
Molecular Weight:135.138
HS Code:2926909090

Physical and Chemical Properties:
Melting point:43-45 °C(lit.)
Boiling point:203.8±20.0 °C at 760 mmHg
Density:1.1±0.1 g/cm3
Index of Refraction:1.508
PSA:23.79000
Exact Mass:135.048431
LogP:1.93

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:3276
Packing Group:III


Contact us for information like 5-Fluoro-2-methylbenzonitrile chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Benzonitrile, 5-fluoro-2-methyl- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-cyano-4-fluorotoluene Use and application,7700578 technical grade,usp/ep/jp grade.


Related News: AZ’s competition isn’t just coming from generics, though. China has a growing biopharma industry where many companies are piling into a few validated drug targets, threatening incumbent foreign drugmakers. 7-hydroxy-3-(2-hydroxy-4,6-dimethoxyphenyl)chromen-4-one manufacturers In Massachusetts, where the bulk of Takeda’s U.S. operations are based since the Shire buyout, the Japanese pharma has been swiftly ramping up its cell therapy ambitions. In September, the company cut the ribbon on a new 24,000-square-foot R&D manufacturing center in Boston, which it said at the time would handle clinical development for three ongoing pipeline programs and two other prospects pegged to enter clinical development by the end of 2021. 5-ethoxy-6-methyl-3,3,7,7-tetrakis-trifluoromethyl-3H,7H-pyrazolo[1,2-a]pyrazole-1,2-dicarboxylic acid dimethyl ester suppliers With the closing of AstraZeneca’s mega $39 billion buyout of Alexion Pharmaceuticals this week, the U.K. pharma has officially picked up Soliris and its successor, Ultomiris. Pentanenitrile, 5-(4-acetyl-3-chloro-2-propylphenoxy)- vendor & factory.